STOCK TITAN

Aziyo Biologics to Participate in the Lytham Partners Spring 2022 Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Aziyo Biologics (Nasdaq: AZYO) announced its participation in the Lytham Partners Spring 2022 Investor Conference, occurring virtually from April 4-7, 2022. The company will present via webcast at 11:00 AM ET on April 4, with the presentation available for replay on its website. Management will also engage in one-on-one meetings during the event. Aziyo focuses on regenerative medicine, developing differentiated products to enhance surgical outcomes, particularly for patients using implantable medical devices. Founded in 2015, the company offers products in cardiovascular, orthopedic, and reconstructive fields.

Positive
  • None.
Negative
  • None.

SILVER SPRING, Md., March 31, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022.

The Company’s webcast presentation will be available for viewing at 11:00am ET on Monday, April 4, 2022, on the Company's website at www.aziyo.com. The webcast will also be archived and available for replay.

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register at www.lythampartners.com/spring2022invreg.

About Aziyo Biologics

Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.

Investors:
Leigh Salvo
Gilmartin Group
investors@aziyo.com


FAQ

What is Aziyo Biologics' participation in the Lytham Partners Spring 2022 Investor Conference?

Aziyo Biologics will participate in the Lytham Partners Spring 2022 Investor Conference virtually from April 4-7, 2022.

When will Aziyo Biologics' webcast presentation take place?

Aziyo Biologics' webcast presentation is scheduled for 11:00 AM ET on April 4, 2022.

Where can I view the Aziyo Biologics webcast presentation?

The webcast presentation can be viewed on Aziyo Biologics' website at www.aziyo.com.

How can I arrange a meeting with Aziyo Biologics management during the conference?

To arrange a meeting, contact Lytham Partners at 1x1@lythampartners.com or register at their website.

What is the focus of Aziyo Biologics?

Aziyo Biologics focuses on regenerative medicine, creating differentiated products to improve outcomes for surgical patients.

When was Aziyo Biologics founded?

Aziyo Biologics was founded in 2015.

Elutia Inc.

:AZYO

AZYO Rankings

AZYO Latest News

AZYO Stock Data

24.21M
4.12M
2.18%
70.44%
0.42%
Medical Devices
Healthcare
Link
United States
Silver Spring